Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers

First Page		Document Content
Date: 2016-03-03 12:17:02 Medicine Clinical medicine Health Healthcare-associated infections Infectious causes of cancer Hepatitis C virus Hepatitis C Hepatitis Viral hepatitis E1 Hepatitis C and HIV coinfection Hepacivac		Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers Add to Reading List Source URL: www.arud.ch Download Document from Source Website File Size: 71,52 KB Share Document on Facebook

	PRESS RELEASE British Columbia Joins Other Provinces to Reimburse AbbVie’s HOLKIRATM PAK  HOLKIRA PAK now reimbursed in British Columbia for patients with genotype 1 hepatitis C virus infection DocID: 1v1Qc - View Document
	227 Towards eradication of hepatitis C virus infection in the Veterans Affairs national healthcare system: a study of 107,079 antiviral treatment regimens administered fromAndrew M. Moon1, Pamela Green2, Krist DocID: 1tab4 - View Document
	Human Anti-Hepatitis C Virus Antibody, Anti-HCV ELISA Kit Cat. No.:DEIA015 Pkg.Size:96T Intended use The Human Anti-Hepatitis C Virus Antibody, Anti-HCV ELISA Kit is designed for the detection of antibodies to Hepatitis DocID: 1t1hr - View Document
	Diagnosing and monitoring Hepatitis C Hepatitis means inflammation of the liver and is often caused by a virus. DocID: 1s7vM - View Document
	論文著述 1. Publication in Journals 1. Tsai MH, Lin KH, Lin KT, Hung CM, Cheng HS, Tyan YC, Huang HW, Sanno-Duanda B, Yang MH, Yuan SS, Chu PY. Predictors for Early Identification of Hepatitis C Virus Infection. Biom DocID: 1rsBL - View Document